adenine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

adenine has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cicala, C; Cirino, G; Morello, S; Severino, B; Sorrentino, L; Vellecco, V	1

Other Studies

1 other study(ies) available for adenine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

Article	Year
Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2. Cardiovascular research, 2003, Nov-01, Volume: 60, Issue:2 Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Aorta; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Nitric Oxide; Oligopeptides; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Receptor, PAR-2; Rolipram; Vasodilator Agents	2003

Article

Year

Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2.

Cardiovascular research, 2003, Nov-01, Volume: 60, Issue:2

Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Aorta; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Nitric Oxide; Oligopeptides; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Receptor, PAR-2; Rolipram; Vasodilator Agents

2003